Summit Therapeutics Inc. financial data

Symbol
SMMT on Nasdaq
Location
Miami, FL
Fiscal year end
31 December
Latest financial report
10-K - Q4 2025 - 23 Feb 2026

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 706% % 33%
Debt-to-equity 18% % -50%
Return On Equity -297% % -257%
Return On Assets -251% % -313%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 775,372,700 shares 4.4%
Common Stock, Shares, Outstanding 775,371,200 shares 5.1%
Entity Public Float $2,483,800,000 USD 200%
Common Stock, Value, Issued $7,754,000 USD 5.1%
Weighted Average Number of Shares Outstanding, Basic 747,702,265 shares 4.1%
Weighted Average Number of Shares Outstanding, Diluted 747,702,265 shares 4.1%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax $0 USD
Research and Development Expense $80,461,000 USD 95%
General and Administrative Expense $556,750,000 USD 825%
Operating Income (Loss) $225,998,000 USD 63%
Nonoperating Income (Expense) $14,838,000 USD 11%
Net Income (Loss) Attributable to Parent $1,079,586,000 USD -388%
Earnings Per Share, Basic -1.44 USD/shares -365%
Earnings Per Share, Diluted -1.44 USD/shares -365%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $225,266,000 USD 115%
Assets, Current $720,301,000 USD 70%
Property, Plant and Equipment, Net $1,059,000 USD 317%
Operating Lease, Right-of-Use Asset $20,616,000 USD 189%
Intangible Assets, Net (Excluding Goodwill) $0 USD
Goodwill $2,001,000 USD 7.4%
Other Assets, Noncurrent $7,205,000 USD 183%
Assets $751,182,000 USD 72%
Accounts Payable, Current $20,292,000 USD 338%
Employee-related Liabilities, Current $14,925,000 USD 25%
Accrued Liabilities, Current $32,100,000 USD 64%
Liabilities, Current $72,988,000 USD 75%
Operating Lease, Liability, Noncurrent $17,502,000 USD 407%
Other Liabilities, Noncurrent $1,832,000 USD 12%
Liabilities $92,322,000 USD 97%
Accumulated Other Comprehensive Income (Loss), Net of Tax $2,540,000 USD -11%
Retained Earnings (Accumulated Deficit) $2,294,159,000 USD -89%
Stockholders' Equity Attributable to Parent $658,860,000 USD 69%
Liabilities and Equity $751,182,000 USD 72%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $61,168,000 USD -103%
Net Cash Provided by (Used in) Financing Activities $7,677,000 USD 1483%
Net Cash Provided by (Used in) Investing Activities $160,110,000 USD 706%
Common Stock, Shares Authorized 1,000,000,000 shares 0%
Common Stock, Shares, Issued 775,371,200 shares 5.1%
Common Stock, Par or Stated Value Per Share 0.01 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect $106,657,000 USD
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $225,582,000 USD 114%
Interest Paid, Excluding Capitalized Interest, Operating Activities $0 USD -100%
Deferred Tax Assets, Valuation Allowance $133,161,000 USD 39%
Deferred Tax Assets, Gross $133,578,000 USD 39%
Operating Lease, Liability $20,890,000 USD 189%
Depreciation $25,000 USD -7.4%
Payments to Acquire Property, Plant, and Equipment $422,000 USD 10450%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent $1,079,841,000 USD -388%
Lessee, Operating Lease, Liability, to be Paid $27,328,000 USD 242%
Property, Plant and Equipment, Gross $1,372,000 USD 10%
Operating Lease, Liability, Current $3,388,000 USD -10%
Lessee, Operating Lease, Liability, to be Paid, Year Two $4,052,000 USD 124%
Lessee, Operating Lease, Liability, to be Paid, Year One $3,492,000 USD -8.1%
Operating Lease, Weighted Average Discount Rate, Percent 0.076 pure 10%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount $6,438,000 USD 740%
Lessee, Operating Lease, Liability, to be Paid, Year Three $4,158,000 USD 340%
Deferred Tax Assets, Operating Loss Carryforwards $73,583,000 USD 24%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 20,000,000 shares 0%
Unrecognized Tax Benefits $3,903,000 USD 84%
Lessee, Operating Lease, Liability, to be Paid, Year Four $3,349,000 USD 215%
Additional Paid in Capital $2,947,805,000 USD 84%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense $732,420,000 USD 1337%
Preferred Stock, Par or Stated Value Per Share 0.01 USD/shares 0%